CD36, a major adhesion molecule expressed by monocytes/macrophages, plays a key role in the binding and internalization of oxidized low-density lipoprotein (OxLDL). This adhesion molecule, a member of an important scavenger receptor family, contains a very short C-terminal cytoplasmic tail that is known to induce intracellular signalling events. However, the domains on the cytoplasmic tail involved in such signal transduction are unknown. In this study, we have investigated the functional components of the cytoplasmic tail by site-directed mutagenesis coupled with functional OxLDL and monoclonal antibody (mAb) binding studies. Seven truncated or punctual CD36 constructs, localized in the cytoplasmic tail, were produced by site-directed mutagenesis. Each construct was stably expressed in HEK293 cells. We used a quantitative and a qualitative method, labelling OxLDL with either iodine or rhodamine, to determine the functional importance of the cytoplasmic domains in OxLDL internalization. Results indicate that: (1) a deletion of the last amino-acid (construct K472STOP) significantly reduces, compared with wild-type, the binding, internalization and degradation of OxLDL; (2) truncation of the last six amino-acids (construct R467STOP) significantly reduces OxLDL binding; (3) the above two constructs (K472STOP and R467STOP) showed a reduced rate of OxLDL internalization compared with wild-type; (4) the binding and rate of internalization of an anti-CD36 monoclonal antibody (10/5) was not affected by the above mentioned mutants (K472STOP and R467STOP), compared with wild-type. This study shows, for the first time, a specific site on the CD36 cytoplasmic tail that is critical for the binding, endocytosis and targeting of OxLDL.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
June 2002
- PDF Icon PDF LinkFront Matter
Research Article|
June 01 2002
The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein Available to Purchase
Eric MALAUD;
Eric MALAUD
∗INSERM U331, Faculty of Medecine RTH Laënnec, 8 Rue Guillaume Paradin, 69372 Lyon Cedex 08, France
Search for other works by this author on:
Delphine HOURTON;
Delphine HOURTON
†INSERM U321, 83 bd de l'Hôpital, Pitié Salpétrière, 75651 Paris Cedex 13, France
Search for other works by this author on:
Louise Marie GIROUX;
Louise Marie GIROUX
†INSERM U321, 83 bd de l'Hôpital, Pitié Salpétrière, 75651 Paris Cedex 13, France
Search for other works by this author on:
Ewa NINIO;
Ewa NINIO
†INSERM U321, 83 bd de l'Hôpital, Pitié Salpétrière, 75651 Paris Cedex 13, France
Search for other works by this author on:
Robin BUCKLAND;
Robin BUCKLAND
‡INSERM U404, Avenue Tony Garnier, 69365 Lyon Cedex 07, France
Search for other works by this author on:
John L. McGREGOR
John L. McGREGOR
1
∗INSERM U331, Faculty of Medecine RTH Laënnec, 8 Rue Guillaume Paradin, 69372 Lyon Cedex 08, France
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
September 27 2001
Revision Received:
January 29 2002
Accepted:
March 13 2002
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2002
2002
Biochem J (2002) 364 (2): 507–515.
Article history
Received:
September 27 2001
Revision Received:
January 29 2002
Accepted:
March 13 2002
Citation
Eric MALAUD, Delphine HOURTON, Louise Marie GIROUX, Ewa NINIO, Robin BUCKLAND, John L. McGREGOR; The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein. Biochem J 1 June 2002; 364 (2): 507–515. doi: https://doi.org/10.1042/bj20011373
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |